1Homes A;Dargere D;Vidaud M.CTGF and SMADs,maintenance of scleroderma phenotype is independent of SMAD signaling,2001(14).
2Rachfal AW;Brigstock DR.Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis[J],2003(01).
3Murphy M;Godson C;Cannon S.Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells,1999(09).
4Frazier KS;Paredes A;Dube P.Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation,2000(04).
5Bradham DM;Igarashi A;Potter RL.Connective tissue growth factor:a cystein-rich mitogen secreted by human vascular endothelial cells is related to SRC-induced immediate early gene product CEF-10,1991(06).
6Ito Y;Aten J;Bende R J.Expression of connective tissue growth factor in human renal fibrosis[J],1998(04).
7Daniels JT;Schultz GS;Blalock TD.Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts:a role for connective tissue growth factor in contractile scarring,2003(05).
8Oemar BS;Werner A;Garnier JM.Human connective tissue growth factor is expressed in advanced atherosclerotic lesions,1997(04).
9Ihn H.The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma,2002(05).
3Nakagawa O,Ogawa Y,hoh H,et al. Evidence for brain natriuretic peptide as an" emergency" cardiac' hormone against ventrieular overload[ J ]. J Clin Invest, 1995,96 ( 3 ) : 1280.
4Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target [J]. Cardiovasc Res, 2000, 46(2) : 225-238.
5Roten L, Nemoto S, Simsic J, et al. Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 ( TIMP-1 ) on left ventricular geometry and function in mice [ J ]. J Mol Cell Cardiol, 2000,32 (1) :109-120.
